Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs. Novo Nordisk on Su… [+7026 chars]Read More
Novo and Lilly are competing to win the GLP1 pill market as they prepare for Medicare coverage CNBC
